Bacteriophage-Delivering Hydrogels: Current Progress in Combating Antibiotic Resistant Bacterial Infection

Antibiotic resistance remains as an unresolved global challenge in the health care system, posing serious threats to global health. As an alternative to antibiotics, bacteriophage (phage) therapy is rising as a key to combating antibiotic-resistant bacterial infections. In order to deliver a phage t...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyun Young Kim (Author), Rachel Yoon Kyung Chang (Author), Sandra Morales (Author), Hak-Kim Chan (Author)
Format: Book
Published: MDPI AG, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_20699d1ff04d4effbd1f33557b7b97c6
042 |a dc 
100 1 0 |a Hyun Young Kim  |e author 
700 1 0 |a Rachel Yoon Kyung Chang  |e author 
700 1 0 |a Sandra Morales  |e author 
700 1 0 |a Hak-Kim Chan  |e author 
245 0 0 |a Bacteriophage-Delivering Hydrogels: Current Progress in Combating Antibiotic Resistant Bacterial Infection 
260 |b MDPI AG,   |c 2021-01-01T00:00:00Z. 
500 |a 10.3390/antibiotics10020130 
500 |a 2079-6382 
520 |a Antibiotic resistance remains as an unresolved global challenge in the health care system, posing serious threats to global health. As an alternative to antibiotics, bacteriophage (phage) therapy is rising as a key to combating antibiotic-resistant bacterial infections. In order to deliver a phage to the site of infection, hydrogels have been formulated to incorporate phages, owing to its favorable characteristics in delivering biological molecules. This paper reviews the formulation of phage-delivering hydrogels for orthopedic implant-associated bone infection, catheter-associated urinary tract infection and trauma-associated wound infection, with a focus on the preparation methods, stability, efficacy and safety of hydrogels as phage carriers. 
546 |a EN 
690 |a bacteriophage (phage) 
690 |a hydrogel 
690 |a multidrug-resistant bacteria 
690 |a formulation 
690 |a efficacy 
690 |a safety 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 10, Iss 2, p 130 (2021) 
787 0 |n https://www.mdpi.com/2079-6382/10/2/130 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/20699d1ff04d4effbd1f33557b7b97c6  |z Connect to this object online.